HER2 Support Group Forums - View Single Post

Jackie07 · 07-15-2010, 07:08 PM

Sassy,
Looks like they are making progresses in the area. Ask your Dad's doctor/nurse if they can get a copy of the full-text of this article for you. I don't really quite understand the title, but I like the tone of the abstract.
Please take good care of yourself while you are trying to take care of your Dad. And do know that we'll be praying for him and your whole family.
Jackie07

Nature Reviews Urology 7, 367-368 (July 2010) | doi:10.1038/nrurol.2010.84

Kidney cancer: Overall survival is an unsuitable primary end point
Giuseppe Di Lorenzo & Carlo Buonerba
Abstract
Treatment of metastatic renal cell carcinoma (mRCC) has evolved from being predominantly cytokine-based to being grounded in the use of drugs targeting the vascular endothelial growth factor (VEGF), platelet-derived growth factor, and mammalian target of rapamycin pathways. An improved understanding of the molecular biology underlying mRCC has led to the development of several new targeted drugs, each with convincing evidence that they provide a clinical benefit, in first-line and second-line usage and in different risk groups.

07-15-2010, 07:08 PM	#4
Jackie07 Senior Member Join Date: Jan 2008 Location: "Love never fails." Posts: 5,809	Re: kidney cancer Sassy, Looks like they are making progresses in the area. Ask your Dad's doctor/nurse if they can get a copy of the full-text of this article for you. I don't really quite understand the title, but I like the tone of the abstract. Please take good care of yourself while you are trying to take care of your Dad. And do know that we'll be praying for him and your whole family. Jackie07 Nature Reviews Urology 7, 367-368 (July 2010) \| doi:10.1038/nrurol.2010.84 Kidney cancer: Overall survival is an unsuitable primary end point Giuseppe Di Lorenzo & Carlo Buonerba Abstract Treatment of metastatic renal cell carcinoma (mRCC) has evolved from being predominantly cytokine-based to being grounded in the use of drugs targeting the vascular endothelial growth factor (VEGF), platelet-derived growth factor, and mammalian target of rapamycin pathways. An improved understanding of the molecular biology underlying mRCC has led to the development of several new targeted drugs, each with convincing evidence that they provide a clinical benefit, in first-line and second-line usage and in different risk groups. __________________ Jackie07 http://www.kevinmd.com/blog/2011/06/doctors-letter-patient-newly-diagnosed-cancer.html http://www.asco.org/ASCOv2/MultiMedi...=114&trackID=2 NICU 4.4 LB Erythema Nodosum 85 Life-long Central Neurocytoma 4x5x6.5 cm 23 hrs 62090 semi-coma 10 d PT OT ST 30 d 3 Infertility tmts 99 > 3 u. fibroids > Pills CN 3 GKRS 52301 IDC 1.2 cm Her2 +++ ER 5% R. Lmptmy SLNB+1 71703 6 FEC 33 R Tamoxifen Recc IIB 2.5 cm Bi-L Mast 61407 2/9 nds PET 6 TCH Cellulitis - Lymphedema - compression sleeve & glove H w x 4 MUGA 51 D, J 49 M Diastasis recti Tamoxifen B. scan Irrtbl bowel 1'09 Colonoscopy 313 BRCA1 V1247I hptc hemangioma Vertigo GI - > yogurt hysterectomy/oophorectomy 011410 Exemestane 25 mg tab 102912 ~ 101016 stopped due to r. hip/l.thigh pain after long walk DEXA 1/13 1-2016 lesions in liver largest 9mm & 1.3 cm onco. says not cancer. 3-11 Appendectomy - visually O.K., a lot of puss. Final path result - not cancer. Start Vitamin D3 and Calcium supplement （600mg x2) 10-10 Stopped Exemestane due to r. hip/l.thigh pain OKed by Onco 11-08-2016 7-23-2018 9 mm groundglass nodule within the right lower lobe with indolent behavior. Due to possible adenocarcinoma, Recommend annual surveilence. 7-10-2019 CT to check lung nodule. 1-10-2020 8mm stable nodule on R Lung, two 6mm new ones on L Lung, a possible lymph node involvement in inter fissule. "I WANT TO BE AN OUTRAGEOUS OLD WOMAN WHO NEVER GETS CALLED AN OLD LADY. I WANT TO GET SHARP EDGED & EARTH COLORED, TILL I FADE AWAY FROM PURE JOY." Irene from Tampa Advocacy is a passion .. not a pastime - Joe Last edited by Jackie07; 07-15-2010 at 07:15 PM..